The gut wellness company Lifechart has raised $500,000 in an early investment round. $250,000 was donated by Prajay Advisors LLP, with the rest funds coming from Agility Ventures, Expert Dojo, and a convertible instrument group of angel investors that included Ahana Gautam, Nitish Mittersain, Sarath Sura, and Marwari Angels.

In 2022, Lifechart had previously raised $200,000 in a pre-seed round led by Nitish Mittersain of Nazara Technologies and Expert Dojo.

According to a press release from the company, the new money will be used to expand Lifechart's key AI capabilities, introduce exclusive diagnostic tools, and build a brand that caters to tier 1 cities.

Mukul Shah and Mansi Sharma co-founded Lifechart in 2022 with the goal of addressing the growing gut health problems in India by providing AI-driven prediction technologies and products made by BAMS and BHMS physicians.

The company intends to launch plant-based microbiome-focused products and all-inclusive health packages that address common digestive problems like gas, fatty liver, constipation, piles, and acidity.

According to industry research, the global market for gut health might reach $18 billion by 2025–2026. Lifechart's initiatives put it in a strong position to take a sizable portion of this market. Mostly in tier II, III, and IV cities, its predictive AI model has already had an influence on over 250,000 clients. Its goal is to customize services based on demographic and geographical health patterns.

Mukul Shah, CEO and Co-Founder of Lifechart says, "We are proud to have attracted the trust of marquee investors, especially during a funding winter. The new capital will be used to enhance our AI capabilities, launch our proprietary diagnostic solutions, and build a new brand targeting Tier 1 cities”.